Home/Filings/4/0000819050-21-000085
4//SEC Filing

McAvoy David R. 4

Accession 0000819050-21-000085

CIK 0000819050other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:43 PM ET

Size

5.5 KB

Accession

0000819050-21-000085

Insider Transaction Report

Form 4
Period: 2021-06-14
McAvoy David R.
General Counsel
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-14+200,000200,000 total
    Exercise: $0.90From: 2022-06-14Exp: 2031-06-14Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The stock options will vest 25% on June 14, 2022, and the remainder will vest in equal monthly installments over the following three years.

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1
  • filerCIK 0001758842

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:43 PM ET
Size
5.5 KB